GL1X · GenesisL1 explorer

Ligand · S4T

S4T · N-(6-(4-(3-(4-((5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)methyl)-3-(trifluoromethyl)phenyl)ureido)phenoxy) pyrimidin-4-yl)cyclopropanecarboxamide

S4T, N-(6-(4-(3-(4-((5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)methyl)-3-(trifluoromethyl)phenyl)ureido)phenoxy) pyrimidin-4-yl)cyclopropanecarboxamide (C29 H27 F3 N8 O3, 592.6 g/mol), in the MolNFT structures on GenesisL1: bound in 2…

Component
S4T
Formula
C29 H27 F3 N8 O3
Class
ligand
Structures
2
PDB entries
1

Binding sites

S4T in 2 structures; the first of them:

  • 7AW1 · MerTK kinase domain in complex with a type 2 inhibitor · S4T A901 · binds LEU593, VAL601, ALA617, LYS619, GLU637, MET641, PHE644, VAL649 and 14 more
  • 7AW1 · Mertk kinase domain in complex with a type 2 inhibitor · S4T A901 · binds VAL601, ALA617, LYS619, GLU637, MET641, PHE644, ILE650, LEU671 and 12 more

Residues it binds most

PHE 2, MET 2, VAL 2, ALA 2, LYS 2, LEU 2, ASP 2, GLU 2, GLY 2, HIS 2 (residue and the binding sites it lines).

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.